MA49488A - Variantes d'anticorps - Google Patents

Variantes d'anticorps

Info

Publication number
MA49488A
MA49488A MA049488A MA49488A MA49488A MA 49488 A MA49488 A MA 49488A MA 049488 A MA049488 A MA 049488A MA 49488 A MA49488 A MA 49488A MA 49488 A MA49488 A MA 49488A
Authority
MA
Morocco
Prior art keywords
antibody variants
variants
antibody
Prior art date
Application number
MA049488A
Other languages
English (en)
Inventor
Esther Furrer
Original Assignee
Tillotts Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tillotts Pharma Ag filed Critical Tillotts Pharma Ag
Priority to MA049488A priority Critical patent/MA49488A/fr
Publication of MA49488A publication Critical patent/MA49488A/fr

Links

MA049488A 2017-09-19 2017-09-19 Variantes d'anticorps MA49488A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MA049488A MA49488A (fr) 2017-09-19 2017-09-19 Variantes d'anticorps

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA049488A MA49488A (fr) 2017-09-19 2017-09-19 Variantes d'anticorps

Publications (1)

Publication Number Publication Date
MA49488A true MA49488A (fr) 2020-05-06

Family

ID=77631567

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049488A MA49488A (fr) 2017-09-19 2017-09-19 Variantes d'anticorps

Country Status (1)

Country Link
MA (1) MA49488A (fr)

Similar Documents

Publication Publication Date Title
MA47694A (fr) Anticorps anti-tigit
MA49034A (fr) Anticorps anti-lag3
MA49043A (fr) Formulation stable d'anticorps
MA53434A (fr) Anticorps anti-tigit
MA47268A (fr) Anticorps anti-gpc3
MA52884A (fr) Anticorps anti-il-11
MA46525A (fr) Anticorps anti-lag-3 et compositions
MA50505A (fr) Anticorps 2 + 1 bispécifiques (contorsbodies)
MA44659A (fr) Anticorps anti-tim-3 et compositions
MA46041A (fr) Anticorps anti-tim -3
MA56006A (fr) Formulations sous-cutanées d'anticorps her2
MA42924A (fr) Variants optimisés d'anticorps anti-vegf
MA44381A (fr) Format d'anticorps hétérodimères multispécifiques
MA52212A (fr) Anticorps multivalent
MA49749A (fr) Anticorps anti-cd137
MA45231A (fr) Anticorps anti-ige
MA49726A (fr) Formulation d'anticorps anti-cgrp
MA44236A (fr) Anticorps anti-tgfbêta 2
MA52152A (fr) Anticorps
MA44054A (fr) Plateforme d'anticorps bispécifique
MA52366A (fr) Anticorps anti-tl1a optimisés
MA42843A (fr) Anticorps anti-cd115
MA54052A (fr) Formulation d'anticorps
MA51134A (fr) Anticorps anti-alpha-synucléine
MA54139A (fr) Formulation d'anticorps